FDANonrulemakingFDA-2018-D-4628
Who commented on this docket
REMS Assessment: Planning and Reporting; Draft Guidance for Industry; Availability
5 organizations filed 5 public comments on REMS Assessment: Planning and Reporting; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2674d ago.
Organizations
5
Comments
5
RIN
—
Comment window
closed 2674d ago
Commenters (5)
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
- Celgene Corporationunverified attribution1 filing · confidence 70%
- International Society of Pharmacoepidemiologytrade assoc.1 filing · confidence 85%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.